Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

  • Bristol Myers is looking to turn its business around, banking on the strong uptake of new drugs. However, the 2025 outlook is not bright and we recommend investors to wait and watch for now.